Time to take CT screening to the next level?

The paper by Pompe et al. [1] in this edition of the European Respiratory Journal investigated subjects from the National Lung Cancer Screening Trial (NLST), whose cause of death was recorded as being a respiratory illness other than lung cancer. The patients’ computed tomography (CT) scans were retrospectively reviewed and compared with the NLST participants of the CT arm who were still alive. Not surprisingly, significantly more lung diseases were detected in those who died from respiratory disease than in the matched control group. Transforming lung cancer screening into a comprehensive programme to detect and treat smoking-related disease early http://ow.ly/b8L5309hUri

[1]  H. Kauczor,et al.  ESR/ERS white paper on lung cancer screening , 2015, European Radiology.

[2]  J. Seo,et al.  The Value of CT for Disease Detection and Prognosis Determination in Combined Pulmonary Fibrosis and Emphysema (CPFE) , 2014, PloS one.

[3]  D. Hogarth,et al.  Smoking cessation: the potential role of risk assessment tools as motivational triggers , 2010, Postgraduate Medical Journal.

[4]  D. Lynch,et al.  Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. , 2013, Radiology.

[5]  P. D. de Jong,et al.  Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality , 2015, Thorax.

[6]  David A Lynch,et al.  Texture-based Quantification of Centrilobular Emphysema and Centrilobular Nodularity in Longitudinal CT Scans of Current and Former Smokers. , 2016, Academic radiology.

[7]  H. Haick,et al.  Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules , 2016, ACS nano.

[8]  Asger Dirksen,et al.  Visual assessment of early emphysema and interstitial abnormalities on CT is useful in lung cancer risk analysis , 2016, European Radiology.

[9]  P. V. van Ooijen,et al.  Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval , 2016, Thorax.

[10]  Arash Naeim,et al.  Cost-effectiveness of CT screening in the National Lung Screening Trial. , 2014, The New England journal of medicine.

[11]  H. Haick,et al.  Non-invasive Breath Analysis of Pulmonary Nodules , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  R. Hubbard,et al.  The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. , 2007, Respiratory medicine.

[13]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[14]  P. Hofman.  Liquid biopsy for early detection of lung cancer , 2017, Current opinion in oncology.

[15]  L. Edwards,et al.  Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality , 2014, Thorax.

[16]  Eckart Meese,et al.  Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. , 2011, Lung cancer.

[17]  N J Wald,et al.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening , 2015, Thorax.

[18]  D. Lynch,et al.  Computed tomographic findings in subjects who died from respiratory disease in the National Lung Screening Trial , 2017, European Respiratory Journal.

[19]  Edwin K Silverman,et al.  CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society. , 2015, Radiology.

[20]  O. Franco,et al.  Coexistence of Calcification, Intraplaque Hemorrhage and Lipid Core within the Asymptomatic Atherosclerotic Carotid Plaque: The Rotterdam Study , 2015, Cerebrovascular Diseases.

[21]  J. Meyer,et al.  Detection of coronary artery calcifications predicting coronary heart disease: comparison of fluoroscopy and spiral CT , 1998, European Radiology.

[22]  N. Becker,et al.  Voraussetzungen für ein erfolgreiches Lungenkrebsscreeningprogramm , 2016, Der Radiologe.

[23]  C. Kuhl,et al.  Extracoronary Thoracic and Coronary Artery Calcifications on Chest CT for Lung Cancer Screening: Association with Established Cardiovascular Risk Factors - The "CT-Risk" Trial. , 2015, Academic Radiology.

[24]  Harry J de Koning,et al.  Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. , 2010, Atherosclerosis.

[25]  K. Chida,et al.  Cumulative incidence of and predictive factors for lung cancer in IPF , 2009, Respirology.

[26]  D. Lynch,et al.  Prevalence and progression of combined pulmonary fibrosis and emphysema in asymptomatic smokers: A case-control study , 2015, European Radiology.

[27]  Scott G. Baginski,et al.  Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. , 2015, Radiology.

[28]  Samuel H. Hawkins,et al.  Predicting Malignant Nodules from Screening CT Scans , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.